Apheresis in the treatment of idiopathic dilated cardiomyopathy

Journal of Clinical Apheresis

Volumn 27, Issue 6, 2012, Pages 312-319

  Winters, Jeffrey L ^a  

^a MAYO CLINIC   (United States)

Author keywords

autoimmunity; dilated cardiomyopathy; immunoadsorption; myocarditis; plasma exchange; plasmapheresis

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEART ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G3; MUSCARINIC M2 RECEPTOR; MYOSIN HEAVY CHAIN ALPHA; POLYCLONAL ANTIBODY; POLYVINYL ALCOHOL; STAPHYLOCOCCUS PROTEIN A; TROPONIN I; TRYPTOPHAN;

APHERESIS; AUTOIMMUNITY; CARDIOVASCULAR MORTALITY; CONGESTIVE CARDIOMYOPATHY; HEART ATRIUM FIBRILLATION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE TACHYCARDIA; HUMAN; IMMUNOADSORPTION; MUSCLE CELL; NONHUMAN; PLASMAPHERESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; REVIEW; SUDDEN DEATH;

ANTIBODIES, HETEROPHILE; AUTOANTIGENS; BLOOD COMPONENT REMOVAL; CARDIOMYOPATHY, DILATED; CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MYOCARDIUM; PLASMA EXCHANGE; POLYVINYL ALCOHOL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, ADRENERGIC, BETA-1; SEPHAROSE; STAPHYLOCOCCAL PROTEIN A; TREATMENT OUTCOME; TRYPTOPHAN;

EID: 84870868870     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21245     Document Type: Review

References (57)

1. Luk A, Ahn E, Soor GS, Butany J,. Dilated cardiomyopathy: a review. J Clin Pathol 2009; 62: 219-225.
2. Abelmann WH, Lorell BH,. The challenge of cardiomyopathy. J Am Coll Cardiol 1989; 13: 1219-1239. (Pubitemid 19114194)
3. Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristo JD, Michels W, Abelmann WH, Harlan WR,. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute Workshop). Am J Cardiol 1992; 69: 1458-1466.
4. Felker GM, Thompson RE, Hare JM, Clemetson DE, Howard DL, Baughman KL, Kasper EK,. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-1084. (Pubitemid 30207690)
5. Yoshikawa T,. Contribution of acquired factors to the pathogenesis of dilated cardiomyopathy-the cause of dilated cardiomyopathy: acquired or genetic? (Acquired-side). Circ J 2011; 75: 1766-1773.
6. Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP,. Viral persistence in myocardium is associated with progressive cardiac dysfunction. Circulation 2005; 112: 1965-1970. (Pubitemid 41377415)
7. Klingel K,. Molecular biologic detection of virus infection in myocarditis and dilated cardiomyopathy. In:, Cooper LT, editor. Myocarditis: From Bench to Bedside. Totowa, NJ: Humana Press. 2002. pp 295-324.
8. Kuethe F, Sigusch HH, Hilbig K, Tresselt C, Gluck B, Egerer R, Figulla HR,. Detection of viral genome in the myocardium: lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy. Am J Heart 2007; 153: 850-858. (Pubitemid 46602143)
9. Cooper LT,. The heat is off: immunosuppression for myocarditis revisited. Eur Heart J 2009; 30: 1936-1939.
10. Lappe JM, Pelfrey CM, Tang WHW,. Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy. J Cardiac Fail 2008; 14: 521-530. (Pubitemid 352043841)
11. Baba A,. Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy. Ther Apher Dial 2008; 12: 109-116. (Pubitemid 351490243)
12. Felix SB, Staudt A,. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects. Int J Cardiol 2006; 112: 30-33. (Pubitemid 44247196)
13. Caforio AL, Mahon NG, Baig MK, Tona F, Murphy RT, Elliott PM, McKenna WJ,. Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 2007; 115: 76-83. (Pubitemid 46058614)
14. Fu ML, Schulze W, Wallukat G, Hjalmarson A, Hoebke J,. A synthetic peptide corresponding to the second extracellular loop of the human M2 acetylcholine receptor induces pharmacological and morphological changes in cardiomyocytes by active immunization after 6 months in rabbits. Clin Immunol Immunopathol 1996; 78: 203-207. (Pubitemid 26084599)
15. Chen J, Larsson L, Haugen E, Fedorkova O, Angwald E, Waaggstein F, Fu M,. Effects of autoantibodies removed by immunoadsorption from patients with dilated cardiomyopathy on neonatal rat cardiomyocytes. Eur J Heart Fail 2006; 8: 460-467. (Pubitemid 44205503)
16. Felix SB, Staudt A, Landsberger M, Grosse Y, Stangl V, Spielhagen T, Wallukat G, Wernecke KD, Baumann G, Stangl K,. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 2002; 39: 646-652. (Pubitemid 34158161)
17. Staudt Y, Trimpert C, Birkenmeier K, Krieg T, Bemmann T, Beug D, Felix SB, Staudt A,. Effects of antibodies obtained from patients with dilated cardiomyopathy on the function of isolated rat hearts. Eur J Clin Invest 2006; 36: 85-90.
18. Jahns R, Boivin V, Schwarzbach V, Ertl G, Lohse MJ,. Pathological autoantibodies in cardiomyopathy. Autoimmunity 2008; 41: 454-461.
19. Staudt A, Eichler P, Trimpert C, Felix SB, Greinacher A,. Fcγ receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol 2007; 49: 1684-1692. (Pubitemid 46589923)
20. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz B,. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010; 25: 83-177.
21. Wallukat G, Reinke P, Dorffel WV, Luther HP, Bestvater K, Felix SB, Baumann G,. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Int J Cardiol 1996; 54: 191-195. (Pubitemid 26188306)
22. Dorffel WV, Felix SB, Wallukat G, Brehme S, Bestvater K, Hofmann T, Kleber FX, Baumann G, Reinke P,. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 1997; 95: 1994-1997. (Pubitemid 27184263)
23. Dorffel WV, Wallukat G, Baumann G, Felix SB,. Immunoadsorption in dilated cardiomyopathy. Ther Apher 2000; 4: 235-238. (Pubitemid 30445878)
24. Dorffel WV, Wallukat G, Dorffel Y, Felix SB, Baumann G,. Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Int J Cardiol 2004; 97: 529-534. (Pubitemid 39550706)
25. 1-adrenoreceptor autoantibodies. Methods Find Exp Clin Pharmacol 2001; 23: 141-144. (Pubitemid 32720611)
26. 1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 2003; 20: 345-350. (Pubitemid 36677526)
27. Muller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Eberhard N, Kunze R, Hetzer R,. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000; 101: 385-391. (Pubitemid 30067394)
28. Schimke I, Muller J, Priem F, Kruse I, Schon B, Stein J, Kunze R, Wallukat G, Hetzer R,. Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol 2001; 38: 178-183. (Pubitemid 32613847)
29. Hessel FP, Wegner C, Muller J, Glaveris C, Wasem J,. Economic evaluation and survival analysis of immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Eur J Health Econ 2004; 5: 58-63. (Pubitemid 38315899)
30. Staudt A, Staudt Y, Dorr M, Bohm M, Knebel F, Hummel A, Wunderle L, Tiburcy M, Wernecke KD, Baumann G, Felix SB,. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol 2004; 44: 829-836. (Pubitemid 39099581)
31. Kallwellis-Opara A, Staudt A, Trimpert C, Moutsias M, Kuhl U, Pauschinger M, Schultheiss HP, Grube M, Bohm M, Baumann G, Volker U, Kroemer HK, Felix SB,. Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathy. J Mol Med 2007; 85: 1429-1435. (Pubitemid 350234098)
32. Felix SB, Staudt A, Dorffel WV, Stangl V, Merkel K, Pohl M, Docke WD, Morgera S, Neumayer HH, Wernecke KD, Wallukat G, Stangl K, Baumann G,. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 2000; 35: 1590-1598. (Pubitemid 30307505)
33. Staudt A, Schaper F, Stangl V, Plagemann A, Bohm M, Merkel K, Wallukat G, Wernecke KD, Stangl K, Baumann G, Felix SB,. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 2001; 103: 2681-2686. (Pubitemid 32538782)
34. Burgstaler EA, Cooper LT, Winters JL,. Treatment of chronic dilated cardiomyopathy with immunoadsorption using the Staphylococcal A-agarose column: a comparison of immunoglobulin reduction using two different techniques. J Clin Apher 2007; 22: 224-232. (Pubitemid 47320237)
35. Staudt A, Bohm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm JB, Borges A, Jochmann N, Wernecke KD, Wallukat G, Baumann G, Felix SB,. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002; 106: 2448-2453. (Pubitemid 35278800)
36. Staudt A, Dorr M, Staudt Y, Bohm M, Probst M, Empen K, Plotz S, Maschke HE, Hummel A, Baumann G, Felix SB,. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption. Am Heart J 2005; 150: 729-736. (Pubitemid 41396508)
37. Staudt A, Staudt Y, Hummel A, Empen K, Dorr M, Trimpert C, Birkenmeier K, Kuhl U, Noutsias M, Russ D, Felix SB,. Effects of immunoadsorption on nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy. Ther Apher Dial 2006; 10: 42-48.
38. Herda LR, Trimpert C, Naike U, Landsberger M, Hummel A, Beug D, Kiebeck A, Dorr M, Empen K, Knebel F, Ewert R, Angelow A, Hoffmann W, Felix SB, Staudt A,. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise in patients with dilated cardiomyopathy. Am Heart J 2010; 159: 809-816.
39. Bulut D, Scheeler M, Niedballa LM, Miebach T, Mugge A,. Effects of immunoadsorption on endothelial function, circulating endothelial progenitors, and circulating microparticles in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol 2011; 100: 603-610.
40. Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Hardy S, Goeser S, Kaya Z, Katus HA, Dengler TJ,. Effects of protein A immunoadsorption in patients with advanced dilated cardiomyopathy. J Clin Apher 2009; 24: 141-149.
41. Doesch AO, Mueller S, Konstandin M, Celik S, Kristen A, Frankenstein L, Goeser S, Kaya Z, Zugck C, Dengler T, Katus HA,. Effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy. J Clin Apher 2010; 25: 315-322.
42. Bulut D, Scheeler M, Wichmann T, Borgel J, Miebach T, Mugge A,. Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol 2010; 99: 633-638.
43. Voigt A, Trimpert C, Bartel K, Egerer K, Kuckelkorn U, Feist E, Gericke C, Klingel K, Kandolf R, Felix SB, Baumann G, Kloetzel PM, Stangl K, Staudt A,. Lack of evidence for a pathogenic role of proteasome-directed autoimmunity in dilated cardiomyopathy. Basic Res Cardiol 2010; 105: 557-567.
44. Trimpert C, Herda LR, Eckerle LG, Pohle S, Muller C, Landsberger M, Felix SB, Staudt A,. Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressnt antibodies. Eur J Clin Invest 2010; 40: 685-691.
45. Staudt A, Herda LR, Trimpert C, Lubenow L, Landsberger M, Dorr M, Hummel A, Eckerle LG, Beug D, Muller C, Hoffmann W, Weitmann K, Klingel K, Kandolf R, Kromer HK, Greinacher A, Felix SB,. Fcγ-receptor IIa polymorphism and the role of immunoadsorption in cardiac dysfunction in patients with dilated cardiomyopathy. Clin Pharacol Ther 2010; 87: 452-458.
46. Cooper LT, Belohlavek M, Korinek J, Yoshifuku S, Sengupta PP, Burgstaler EA, Winters JL,. A pilot study to assess the safety of protein A immunoadsorption for chronic dilated cardiomyopathy. J Clin Apher 2007; 22: 210-214. (Pubitemid 47320235)
47. Staudt A, Hummel A, Ruppert J, Dorr M, Trimpert C, Birkenmeier K, Krieg T, Staudt Y, Felix SB,. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J 2006; 152: 712.e1-712.e6.
48. http://clinicaltrials.gov/ct2/show/NCT00558584. Accessed on June 13, 2012.
49. Schimke I, Muller J, Dandel M, Gremmels HD, Bayer W, Wallukat B, Wallukat G, Hetzer R,. Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: data of a preliminary study. J Clin Apher 2005; 20: 137-142. (Pubitemid 43081861)
50. 1- adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy. New Engl J Med 2002; 347: 1806. (Pubitemid 35375628)
51. Dandel M, Wallukat G, Englert A, Lehmkuhl HB, Hetzer R,. Efficacy of immunoadsorption as bridge-to-transplant therapy in patients with idiopathic dilated cardiomyopathy and evidence of beta-1 adrenoreceptor autoantibodies. J Heart Lung Transpl 2010; 20 (Suppl 2S): S163-S164.
52. Nagatomo Y, Baba A, Ito H, Naito K, Yoshizawa A, Kurita Y, Nakamura I, Monkawa T, Matsubara T, Wakabayashi Y, Ogawa S, Akaishi M, Yoshikawa T,. Specific immunoadsorption therapy using tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy. J Clin Apher 2011; 26: 1-8.
53. Yazaki Y, Horigome M, Kasai H, Ikeda U,. Follow-up of two cases with dilated cardiomyopathy treated with immunomodulation. J Card Fail 2009; 15 (Suppl): S174.
54. http://clinicaltrials.gov/ct2/show/NCT01478087. Accessed on June 13, 2012.
55. 1-adrenergic receptor antibody in a patient with dilated cardiomyopathy. J Clin Apher 2007; 22: 241-242. (Pubitemid 47320239)
56. Sugiyama H, Hoshiai M, Sugita K, Matsuda K,. Plasma exchange for removal of antibeta1-adrenergic receptor antibody in a small child with dilated cardiomyopathy. Pediatr Cardiol 2009; 30: 374-376.
57. Torre-Amione G, Orrego CM, Khalil N, Kotther-Assad C, Leveque C, Celis R, Youker KA, Estep JD,. Therapeutic plasma exchange a potential strategy for patients with advanced heart failure. J Clin Apher 2010; 25: 323-330.